Ionis Pharmaceuticals (IONS) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Ionis Pharmaceuticals (IONS) over the last 11 years, with Q4 2024 value amounting to $97.7 million.
- Ionis Pharmaceuticals' Accumulated Depreciation & Amortization rose 1083.68% to $97.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $97.7 million, marking a year-over-year increase of 1083.68%. This contributed to the annual value of $97.7 million for FY2024, which is 1083.68% up from last year.
- Per Ionis Pharmaceuticals' latest filing, its Accumulated Depreciation & Amortization stood at $97.7 million for Q4 2024, which was up 1083.68% from $88.2 million recorded in Q4 2023.
- Ionis Pharmaceuticals' Accumulated Depreciation & Amortization's 5-year high stood at $97.7 million during Q4 2024, with a 5-year trough of $64.3 million in Q4 2020.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $79.6 million (2021), whereas its average is $81.8 million.
- Per our database at Business Quant, Ionis Pharmaceuticals' Accumulated Depreciation & Amortization surged by 2623.3% in 2020 and then plummeted by 55.79% in 2022.
- Over the past 5 years, Ionis Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $64.3 million in 2020, then grew by 23.75% to $79.6 million in 2021, then fell by 0.56% to $79.1 million in 2022, then grew by 11.43% to $88.2 million in 2023, then increased by 10.84% to $97.7 million in 2024.
- Its Accumulated Depreciation & Amortization stands at $97.7 million for Q4 2024, versus $88.2 million for Q4 2023 and $79.1 million for Q4 2022.